FDA expands diazepam nasal spray for seizure clusters to ages 2–5
Diazepam nasal spray (Valtoco) is approved for short-term treatment of seizure clusters, now in patients aged 2 years and older.
PODCAST: Auditory brain stem implants in young children.
Jamie Glater, MD, discusses an NIH-sponsored study investigating the effectiveness of an auditory brain stem implant in young children with congenital cochlear nerve agenesis.
Preterm birth associated with long-term cognitive issues in children
Infants born moderately preterm had lower composite cognitive scores compared to those born at full-term s (β = −0.39; 95% CI, −0.55 to −0.22; P < .001).
FDA accepts sBLA to expand fremanezumab-vfrm indication for episodic migraines in children
If approved, the expanded indication would include children and adolescents aged 6 to 17 years who weigh 99 lbs (45 kg) or more.
Navepegritide NDA submitted to treat children with achondroplasia
Submission is based on 3 clinical trials, including data from the ApproaCH Trial among children with achondroplasia.
FDA approves diazoxide choline extended-release tablets for hyperphagia in Prader-Willi syndrome
Diazoxide choline has been granted breakthrough, fast track, and orphan drug designations in the United States.
